tiprankstipranks
Verastem Inc. at a Crossroads: Navigating the Perilous Terrain of Patent Ownership and IP Rights
Company Announcements

Verastem Inc. at a Crossroads: Navigating the Perilous Terrain of Patent Ownership and IP Rights

Verastem Inc (VSTM) has disclosed a new risk, in the Trade Secrets category.

Verastem Inc. faces a significant business risk pertaining to the ownership and inventorship of its patents and intellectual property (IP). Despite entering into agreements that stipulate the assignment of inventions to the company, there is no guarantee these will be adhered to or effectively transfer IP rights to Verastem Inc. Disputes may arise, particularly in collaborative or sponsored research contexts, challenging the company’s IP claims. Such legal battles could incur considerable costs and, in an adverse outcome, result in the loss of IP rights critical to Verastem Inc.’s operations.

The average VSTM stock price target is $31.67, implying 187.91% upside potential.

To learn more about Verastem Inc’s risk factors, click here.

Related Articles
TheFlyVerastem doses first patient in GFH375/VS-7375 trial
TheFlyVerastem price target lowered to $18 from $34 at Truist
TheFlyVerastem to be added to the Russell 3000 & Microcap Indexes effective July 1
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!